CHARLESTON, S.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), through its wholly-owned subsidiary, (“Aeterna”...
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) today announced that it has entered...
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) presented a poster today at...
DUBLIN, Ireland, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational,...
CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on...
Bilayer tablet patent application could provide U.S. patent coverage for Iterum’s commercial formulation through 2039, if grantedDUBLIN, Ireland and CHICAGO,...
MYC amplification found in approximately 30% of solid tumors Phase 1/2 clinical trial to begin in the first quarter of...
Studies further support itolizumab’s potential as treatment for aGVHD patientsLA JOLLA, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc....
6-month Priority Review granted for ibrexafungerp with PDUFA target action date set for June 1, 2021FDA indicated that it is...
NEWARK, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Teneobio, Inc., a clinical stage biotech company focused on discovery and development...
LOS ANGELES, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Cannabis Global, Inc. (OTC: CBGL), an innovation-oriented company investing in disruptive cannabis...
Expect to dose first patient in January 2021 and report interim data mid-2021 Success in nontuberculous mycobacteria (NTM) at-home study...
Completes Acquisition of IBA; Finishes Fiscal 2020 with Annual Revenue of $209.2 Million and $0.54 EPSATLANTA, Dec. 07, 2020 (GLOBE...
Robust signals of clinical efficacy, with ORR of 85%, of which 64% are CR/CRiLongest remission to date 690 days, still...
Gold-Tipped Force Sensing Ablation Catheter Earns CE Mark, Expanding Acutus’ Comprehensive Electrophysiology Portfolio AcQBlate FORCE Sensing Ablation System A complete...
DARE-BV1 met the primary endpoint of the study and all pre-specified secondary efficacy endpoints; demonstrated significantly greater clinical cure rates...
MARIETTA, Ga., Dec. 07, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader...
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that world-renowned...
Best objective response rate of 87% reported for 15 patients with relapsed/refractory mantle cell lymphoma, with a median follow-up of...
CRL did not identify clinical deficienciesBURLINGTON, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company...